"Designing Growth Strategies is in our DNA"

U.S. Anti-Inflammatory Biologics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitor, and Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: January 27, 2025 | Format: PDF | Report ID: FBI109142

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 6.1% from 2023 to 2030

Unit

Value (USD Billion)

Segmentation

By Drug Class

  • Anti-Tumor Necrosis Factor (TNF)
  • Interleukin Antagonists
  • Janus Kinase (JAK) Inhibitors
  • Others

By Application

  • Rheumatoid Arthritis
  • Psoriasis
  • Others

By Route of Administration

  • Oral
  • Injection
    • Intravenous
    • Subcutaneous

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase